Trial Profile
Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Colchicine (Primary)
- Indications Pericarditis
- Focus Therapeutic Use
- Acronyms CORP2
- 18 Apr 2014 New trial record
- 30 Mar 2014 Primary endpoint 'Disease-recurrence-rate' has been met.
- 30 Mar 2014 Results published in the Lancet.